SCHEMBL23710238

SCHEMBL23710238

COC(=O)CC[C@H](N)C(=O)N1CCCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=O)C(N)=O)c1c[nH]c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 4/20 0.41
▸ OPRM1 P35372 2/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ TACR1 P25103 1/20 0.40
▸ CXCR4 P61073 3/20 0.39
▸ NTSR2 O95665 1/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ SORT1 Q99523 1/20 0.39
▸ DPP3 Q9NY33 1/20 0.38
▸ TACR2 P21452 2/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSH P09668 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ CAPN1 P07384 1/20 0.38
▸ CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23710189 0.91 CTSL (0.41) KISS1ROPRM1CXCR4CTSLCTSH
SCHEMBL23710225 0.91 CTSL (0.41) KISS1ROPRM1CXCR4CTSLCTSH
SCHEMBL23710234 0.89 KISS1R (0.52) KISS1ROPRM1OPRD1OPRK1TACR1
SCHEMBL23700288 0.82 KISS1R (0.53) KISS1ROPRM1TACR1CXCR4NTSR2
SCHEMBL23700286 0.82 KISS1R (0.53) KISS1ROPRM1TACR1CXCR4NTSR2
SCHEMBL23700290 0.82 KISS1R (0.53) KISS1ROPRM1TACR1CXCR4NTSR2
SCHEMBL23710188 0.81 OPRM1 (0.51) KISS1ROPRM1TACR1CXCR4CTSL
SCHEMBL23710223 0.80 OPRM1 (0.50) KISS1ROPRM1TACR1CXCR4CTSL
SCHEMBL23710323 0.80 CAPN1 (0.49) KISS1ROPRM1TACR1CXCR4TACR2
SCHEMBL23710322 0.80 KISS1R (0.45) KISS1ROPRM1TACR1CXCR4TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238225-A1 PEPTIDOMIMETIC INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1) DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238225-A1 PEPTIDOMIMETIC INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1) PIN1, PPIA, PPIE KISS1R 4542/4885OPRM1 3964/4885OPRD1 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback